Women’s and Newborn Health
The Women's and Newborn Health Network is led by a steering committee responsible for governance, engagement, and supporting the education and research agenda of Women's and Newborn Health across the MACH sites.
Chaired by Professor Sue Walker AO, the Women’s and Newborn Health committee includes clinical and research expertise in key specialist areas such as preeclampsia, endometriosis, cancer, fetal medicine, newborn health, fertility and menopause.
Chair
The network aims to address key areas, including:
- Enabling opportunities for collaboration across the network
- Supporting research, and translation of research into practice, of topics affecting women and infants, issues that broadly affect the community but need to be viewed differently when patients are women, and research that utilises a gender lens more effectively
- Identifying and disseminating relevant funding opportunities
| Name: | Affiliations: | Bio: |
|---|---|---|
| Professor Jeanie Cheong | Murdoch Children's Research Institute, Royal Women’s Hospital | Full Bio |
| Emily Condon | Consumer representative | |
| Dr Oliver Daly | Western Health | Full Bio |
| Professor Della Forster | La Trobe University, Royal Women’s Hospital | Full Bio |
| Associate Professor Helena Frawley | Royal Women's Hospital, Mercy Hospital, University of Melbourne | Full Bio |
| Professor Denise Harrison | University of Melbourne | Full Bio |
| Dr Leah Hickey | Royal Children's Hospital, University of Melbourne | Full Bio |
| Professor Martha Hickey | Mercy Hospital, Royal Women’s Hospital | Full Bio |
| Associate Professor Lisa Hui | Mercy Hospital, Northern Health, University of Melbourne | Full Bio |
| Dr Stefan Kane | Royal Women’s Hospital | Full Bio |
| Associate Professor Joanne Said | Royal Women’s Hospital, University of Melbourne, Western Health | Full Bio |
| Professor Sue Walker AO | Mercy Hospital, University of Melbourne | Full Bio |
-
‘Find and Follow’: scoping the data capture, reporting and follow-up of (i) pregnancies complicated by congenital abnormalities, (ii) health and development among ‘high risk’ newborns.
Read more of the ‘Find and Follow’: scoping the data capture, reporting and follow-up of (i) pregnancies complicated by congenital abnormalities, (ii) health and development among ‘high risk’ newborns.
Letter – Consider pregnancy in COVID-19 therapeutic drug and vaccine trials
The Lancet, May 2020, Prof Susan Walker, Chair MACH Women’s and Newborn Health Committee
-
Implementation Science Resource Directory
Read more of the Implementation Science Resource Directory